{"id":14430,"date":"2021-05-19T08:48:03","date_gmt":"2021-05-19T08:48:03","guid":{"rendered":"https:\/\/clinlabint.com\/?p=14430"},"modified":"2021-05-19T08:48:03","modified_gmt":"2021-05-19T08:48:03","slug":"bio-rad-launches-its-reliance-sars-cov-2-rt-pcr-assay-kit-in-europe","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/bio-rad-launches-its-reliance-sars-cov-2-rt-pcr-assay-kit-in-europe\/","title":{"rendered":"Bio-Rad launches its Reliance SARS-CoV-2 RT-PCR assay kit in Europe"},"content":{"rendered":"
<\/p>\n
Bio-Rad Laboratories has launched its Reliance SARS-CoV-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements. The Reliance SARS-CoV-2 RT-PCR Kit is a real-time reverse-transcription PCR (RT-PCR) test that can detect nucleic acid in SARS-CoV-2,\u00a0the virus associated with COVID-19 disease.\u00a0A version of the assay kit is also available in the United States under an U.S. FDA emergency use authorization (EUA).<\/p>\n
The Reliance SARS-CoV-2 RT-PCR Kit (IVD) is designed for clinical diagnostic labs that conduct COVID-19 testing. The assay kit offers the qualitative detection of two separate target regions in the nucleocapsid gene (N1 and N2 regions) of SARS-CoV-2 in nasopharyngeal swab specimens from individuals suspected of being infected by COVID-19.<\/p>\n
Because the test are designed to target the nucleocapsid gene, the assay\u2019s performance is not affected by known coronavirus variants as determined by in-silico analysis. The assay kit contains Bio-Rad\u2019s standard and negative molecular controls as well as assay reagents. It is validated to run on Bio-Rad\u2019s CFX96 Dx RT-PCR system, as well as RT-PCR systems from other manufacturers.<\/p>\n
\u201cWe are excited about the European launch of our SARS-CoV-2 RT-PCR Kit (IVD), a reliable, sensitive, and accurate solution for COVID-19 testing,\u201d said Steven Blakely, Bio-Rad Global Director of Marketing, Life Science Group, Gene Expression. \u201cTesting laboratories worldwide use Bio-Rad\u2019s RT-PCR systems for the detection of SARS-CoV-2. The assay kit is the latest addition to our COVID-19 offering of research and testing products, reflecting our ongoing commitment to helping in the fight against COVID-19,” he said.<\/p>\n